Sheel Biotech Ltd
Incorporated in November 1994, Sheel Biotech Limited specializes in biotechnology, floriculture, greenhouses, and organic projects.[1]
- Market Cap ₹ 127 Cr.
- Current Price ₹ 62.5
- High / Low ₹ 86.5 / 37.8
- Stock P/E 10.8
- Book Value ₹ 62.4
- Dividend Yield 0.00 %
- ROCE 13.5 %
- ROE 11.2 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 1.00 times its book value
- Company has delivered good profit growth of 20.2% CAGR over last 5 years
Cons
- The company has delivered a poor sales growth of 11.8% over past five years.
- Company has a low return on equity of 13.0% over last 3 years.
- Company has high debtors of 205 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Diversified Commercial Services
Part of Nifty SME Emerge
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 63 | 84 | 89 | 103 | 102 | 110 | |
| 56 | 78 | 80 | 89 | 87 | 94 | |
| Operating Profit | 7 | 6 | 9 | 14 | 15 | 16 |
| OPM % | 10% | 8% | 10% | 14% | 15% | 15% |
| 0 | 0 | 0 | 0 | 1 | 1 | |
| Interest | 1 | 1 | 2 | 1 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 5 | 5 | 6 | 12 | 13 | 14 |
| Tax % | 0% | 2% | 20% | 15% | 16% | 16% |
| 5 | 5 | 5 | 10 | 11 | 12 | |
| EPS in Rs | 3.31 | 3.11 | 3.50 | 7.22 | 7.20 | 5.78 |
| Dividend Payout % | 0% | 28% | 25% | 12% | 14% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 7% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 20% |
| 3 Years: | 32% |
| TTM: | 13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -20% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | 13% |
| Last Year: | 11% |
Balance Sheet
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 15 | 20 |
| Reserves | 53 | 56 | 59 | 69 | 69 | 107 |
| 21 | 24 | 19 | 24 | 17 | 9 | |
| 4 | 10 | 11 | 10 | 10 | 10 | |
| Total Liabilities | 82 | 93 | 94 | 106 | 111 | 146 |
| 8 | 8 | 8 | 7 | 7 | 9 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 3 |
| Investments | 0 | 1 | 1 | 1 | 1 | 1 |
| 75 | 84 | 85 | 98 | 103 | 132 | |
| Total Assets | 82 | 93 | 94 | 106 | 111 | 146 |
Cash Flows
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 2 | 9 | -1 | 9 | -18 | ||
| -2 | -2 | -0 | -2 | -7 | ||
| -0 | -7 | 2 | -6 | 26 | ||
| Net Cash Flow | -0 | -0 | 0 | -0 | 2 | |
| Free Cash Flow | 1 | 8 | -1 | 7 | -24 | |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 37% | 105% | 3% | 71% | -94% |
Ratios
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 352 | 280 | 230 | 204 | 198 | 205 |
| Inventory Days | 55 | 120 | 177 | 263 | 272 | 212 |
| Days Payable | 30 | 85 | 75 | 37 | 29 | 22 |
| Cash Conversion Cycle | 377 | 315 | 332 | 430 | 441 | 395 |
| Working Capital Days | 348 | 274 | 255 | 256 | 275 | 361 |
| ROCE % | 7% | 10% | 15% | 14% | 13% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Segment Revenue Share % of total revenue |
|
|||
| Top 10 Customer Revenue Concentration % of revenue from operations |
||||
| Farmers Reached Under Organic Programs count |
||||
| Number of Farmer Producer Organizations (FPOs) count |
||||
| Number of Permanent Employees count |
||||
| States of Operation (Organic Farming) count |
||||
| Tissue Culture Production Capacity million plants per annum |
||||
Extracted by Screener AI
Documents
Announcements
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
- Sheel Biotech Limited has informed about Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Integrated Filing- Governance
- Statement of Investor Complaints under Regulation 13(3) of SEBI (LODR), 2015 for the quarter ended 30th Sept, 2026.
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
- Sheel Biotech Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q2 FY 2026
-
Updates
- Sheel Biotech Limited has informed regarding ' Award of Work having contract value of Rs. 4.54 Crore from the Department of Agriculture, Government of Himachal …
-
Trading Window
- Sheel Biotech Limited has informed regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Business Overview:[1]
SBL is a leading agri-horticultural solutions company in India, which offers premium quality tissue culture
planting material, protected cultivation infrastructure, and organic farming programs under the Sheel Biotech brand. The company caters to the evolving needs of India's farmers, institutions, and urban landscaping market.